Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call
03 Mai 2024 - 1:05PM
PR Newswire (Canada)
MISSISSAUGA, ON, May 3, 2024
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF)
("Cipher" or the "Company") today announced that it
will release its financial results for the first quarter of 2024
after the market close on Thursday, May 9,
2024. The Company will also hold a conference call on
Friday, May 10, 2024 at 8:30 ET to discuss the results and corporate
developments.
CONFERENCE CALL DETAILS
DATE:
|
May 10, 2024
|
TIME:
|
8:30AM
|
DIAL-IN NUMBER:
|
416-764-8650 or
888-664-6383
|
REPLAY:
|
416-764-8677 or
888-390-0541 Code:196164#
|
|
Expires: May 17,
2024
|
WEBCAST:
|
https://app.webinar.net/ZQPqmBaVGEn
|
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals (TSX:CPH) (OTCQX:CPHRF) is a specialty
pharmaceutical company with a robust and diversified portfolio of
commercial and early to late-stage products. Cipher acquires
products that fulfill unmet medical needs, manages the required
clinical development and regulatory approval process, and currently
markets those products either directly in Canada or
indirectly through partners in Canada, the U.S.,
and South America. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2024 Canada NewsWire
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024